Search results
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 3 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Fox News misinterprets results of study to blame millions of “excess deaths” on the COVID-19 vaccine
Media Matters· 45 minutes agoWritten by Helena Hind Published 06/13/24 9:21 AM EDT
Vaccine critics misrepresent US appeals court ruling over Covid-19 shots
AFP via Yahoo News· 2 days agoVaccine skeptics are claiming a US federal appeals court ruled in June 2024 that Covid-19 shots are...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via AOL· 3 hours agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
The COVID-19 vaccines shouldn't have been free
Reason.com· 2 weeks agoThe two argue the tremendous benefits of the COVID-19 vaccines for the elderly were undercut by government guidance and messaging that ...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
KAAL Austin· 20 hours agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WYFF 4 Greenville· 7 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 22 hours agoAt this time, mRNA-1083 is poised to be the first Covid-19/influenza combination vaccine and the...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 3 hours agosaid Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
Digital Journal· 3 hours agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-< ...